Features | Partner Sites | Information | LinkXpress
Sign In
GLOBETECH PUBLISHING LLC
PURITAN MEDICAL
GLOBETECH PUBLISHING LLC

New Module Enables Super-Resolution Microscopy of Cell Organelles in Three Dimensions

By BiotechDaily International staff writers
Posted on 20 Nov 2013
Image: The ELYRA super-resolution microscope system enables 3D-PALM imagery (Photo courtesy of Zeiss).
Image: The ELYRA super-resolution microscope system enables 3D-PALM imagery (Photo courtesy of Zeiss).
Biotech researchers and other life scientists who employ advanced microscopy techniques are now able to move up to a state-of-the-art super-resolution microscopy system.

Zeiss (Jena, Germany) has introduced ELYRA P.1, a new module that makes possible three-dimensional (3D) super-resolution photoactivated localization microscopy (PALM) for endogenously-expressed photo-switchable fluorescent proteins.

In PALM, photo-switchable fluorescent molecules are sparsely activated so that only one out of many will be in its on-state within a single point spread function (PSF). In 3D, the PSF shape codes for the z-position. The localizations are plotted in a new image to create the super-resolved image. ELYRA P.1 achieves resolutions in the range of 20–30 nanometers laterally and 50–80 nanometers axially. The ELYRA P.1 module captures highly resolved structures in 3D, while treating the sample so gently that it remains available for long-term observation.

The ELYRA system can be integrated with the Zeiss laser scanning microscopes LSM 710 or LSM 780. In addition, ELYRA works seamlessly together with Zeiss scanning electron microscopes.

“With ELYRA, researchers can investigate the structural arrangement of one or multiple proteins, reveal the ultrastructure of cell organelles in 2D and 3D as well as map and count molecules within a structure. Sophisticated algorithms relate photon statistics to precision information in all directions, so researchers can display their structures fully rendered in 3D,” said Dr. Klaus Weisshart, ELYRA product manager at Zeiss.

Related Links:

Zeiss



Channels

Genomics/Proteomics

view channel
Image: Nomarski interference contrast photomicrographs of Cryptosporidium in the feces of an HIV-positive human (Photo courtesy of the CDC - [US] Centers for Disease Control and Prevention).

Advanced Genetic Tools Revamp Search for Drugs to Treat Cryptosporidium

Genetically engineered modifications to genome of the diarrhea-causing parasite Cryptosporidium are expected to expedite research towards vaccine and drug development to prevent or cure infection by this pathogen.... Read more

Drug Discovery

view channel
Image: A new micelle delivery system for the protective polyphenols resveratrol and quercetin (mRQ) may have value in cancer chemotherapy (Photo courtesy of Oregon State University).

Micelles Containing Resveratrol and Quercetin Reverse Doxorubicin Cardiotoxicity

Cancer researchers blocked the toxic effects of the cancer drug doxorubicin (DOX) by administering it together with the plant antioxidants resveratrol and quercetin. Although in use for more than 40... Read more

Business

view channel

Teva Buys Allergan Generic Business Unit

Teva Pharmaceutical Industries (Petah Tikva, Israel) has bought the Allergan (Irvine, CA, USA) generic drugs business for USD 40.5 billion in cash and stock, solidifying its position as the world's largest generic drug maker. Under the terms of the agreement, Teva will pay USD 33.75 billion in cash and USD 6.... Read more
 
Copyright © 2000-2015 Globetech Media. All rights reserved.